SAGE Launches New Medical Journal Series

["Johns, Valerie" <Valerie.Johns@sagepub.com>]

***Apologies for cross posting***

SAGE Launches New Medical Journal Series

Los Angeles, London, New Delhi, and Singapore (September 6, 2007) 
- SAGE, the world's fifth largest journals publisher, is 
delighted to announce the launch of a new journals series 
dedicated to the latest therapies for major world-wide diseases.

The series, encompassing the highest quality peer-reviewed 
scholarly content, will focus on ground-breaking studies of 
cardiovascular and respiratory diseases, pharmacology and 
medicine.

The first journal in the series, Therapeutic Advances in 
Cardiovascular Disease, was launched on September 2nd at the 
European Society of Cardiology Annual Congress in Vienna, 
Austria. The first issue is available online at 
http://tac.sagepub.com.

The second journal, Therapeutic Advances in Respiratory Disease 
will follow on September 15th at the European Respiratory Society 
Annual Congress in Stockholm, Sweden. The first issue is also now 
available online at http://tar.sagepub.com.

"Launching a new journal in an already crowded field is a 
daunting task," commented Editor-in-Chief of Therapeutic Advances 
in Cardiovascular Disease, Carlos M. Ferrario, of North 
Carolina's Wake Forest University School of Medicine. "But there 
is a need for a timely journal that analyzes new therapies for 
cardiovascular disease. Our first issue (September) addresses 
cardio-metabolic syndrome and its possible therapies."

"There is also a real need for a journal to serve the pulmonary 
research community" agreed Editor-in-Chief of the second journal, 
Mario Cazzola, of the University of Rome'Tor Vergata' in Italy. 
"I'm delighted to launch Therapeutic Advances in Respiratory 
Disease, not to compete with existing journals, but to complement 
them. It can be difficult to get smaller studies published in the 
larger journals, despite the significance of the research, 
especially for authors whose first language is not English. With 
SAGE's first-class production and editing facilities, this will 
be a platform for all significant research and debate in 
respiratory pharmacology."

"We're very excited by the launch of the Therapeutic Advances 
journals," added Ziyad Marar, SAGE Deputy Managing Director and 
Publishing Director. "Our investment in the series reflects 
SAGE's continued commitment to our STM publishing program, 
complementing our established reputation as the market leader in 
the social sciences."

Published bi-monthly starting with Volume 2 in February 2008, the 
journals are aimed at clinicians and researchers in the fields of 
cardiovascular and respiratory diseases and will be a forum for 
all views in these disciplines.

Free online trials to Volume 1 of both journals are available 
until December 31, 2007. To register for the Therapeutic Advances 
in Cardiovascular Disease trial, go to 
https://online.sagepub.com/cgi/register?registration=TAK.  To 
register for the Therapeutic Advances in Respiratory Disease 
trial, go to 
https://online.sagepub.com/cgi/register?registration=tar.

Future launches in the series include Therapeutic Advances in 
Urology & Nephrology, Gastroenterology & Hepatology, Neurological 
Disorders, and others.

###


CONTACTS:
Valerie Johns
Senior Marketing Manager
SAGE Publications
valerie.johns@sagepub.com

Mary Kay Jezzini
SAGE Publicist
publicity@sagepub.com